DIMETHYL FUMARATE vs GLATIRAMER

Compare DIMETHYL FUMARATE (Dimethyl Fumarate) and GLATIRAMER (Glatiramer Acetate) — clinical data, side effects, and patient experiences.

DIMETHYL FUMARATE

Dimethyl Fumarate, Tecfidera · Other

How it works

12.1 Mechanism of Action The mechanism by which dimethyl fumarate (DMF) exerts its therapeutic effect in multiple sclerosis is unknown. DMF and the metabolite, monomethyl fumarate ...

Approved for

1 INDICATIONS AND USAGE Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)

to include clinically isolated syndrome

relapsing-remitting disease

and active secondary progressive disease

OralTablet

GLATIRAMER

Glatiramer Acetate · Other

How it works

12.1 Mechanism of Action The mechanism(s) by which glatiramer acetate exerts its effects in patients with MS are not fully understood. However, glatiramer acetate is thought to act...

Approved for

1 INDICATIONS AND USAGE Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS)

to include clinically isolated syndrome

relapsing-remitting disease

and active secondary progressive disease

SubcutaneousTablet

Quick Comparison

DIMETHYL FUMARATEGLATIRAMER

Drug Class

Other

Route

Oral

Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

DIMETHYL FUMARATE

Nausea

1-10%

Diarrhea

1-10%

Fatigue

1-10%

Vomiting

1-10%

Drug Not Working

1-10%

Headache

0.1-1%

Itching

0.1-1%

Falls

0.1-1%

GLATIRAMER

Injection Site Pain

>10%

Drug Not Working

1-10%

Injection Site Reaction

1-10%

Fatigue

1-10%

Shortness of Breath

1-10%

Falls

1-10%

Nausea

0.1-1%

Dizziness

0.1-1%

FDA Warnings

DIMETHYL FUMARATE

5 WARNINGS AND PRECAUTIONS Anaphylaxis and angioedema: Discontinue and do not restart dimethyl fumarate if these occur
2 ) Herpes zoster and other serious opportunistic infections: Consider withholding dimethyl fumarate in cases of serious infection until the infection has resolved
PML is an opportunistic viral infection of the brain caused by the JC virus (JCV) that typically only occurs in patients who are immunocompromised, and that usually leads to death or severe disability
A fatal case of PML occurred in a patient who received dimethyl fumarate for 4 years while enrolled in a clinical trial

GLATIRAMER

5 WARNINGS AND PRECAUTIONS • Immediate Post-Injection Reaction (flushing, chest pain, palpitations, tachycardia, anxiety, dyspnea, throat constriction, and/or urticaria), may occur within seconds to minutes after injection and are generally transient and self-limiting ( 5
6 ) • Glatiramer Acetate Products and Administration Errors: Using an optional autoinjector that is not compatible for use with Mylan’s glatiramer acetate injection may increase the risk for medication errors, such as dose omission or administration of a partial dose
1 Anaphylactic Reactions Life-threatening and fatal anaphylaxis has been reported with glatiramer acetate injection [see Adverse Reactions (6
Glatiramer acetate injection is contraindicated in patients with a history of hypersensitivity reactions to glatiramer acetate injection, including anaphylaxis [see Contraindications (4) ]

Clinical Trial Data

No head-to-head clinical studies found for DIMETHYL FUMARATE vs GLATIRAMER.

DIMETHYL FUMARATE vs GLATIRAMER: What You Should Know

Key Differences

Both DIMETHYL FUMARATE and GLATIRAMER belong to the Other class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. DIMETHYL FUMARATE is administered via Oral, whereas GLATIRAMER uses Subcutaneous. Route of administration can affect onset of action and patient adherence.

Shared Indications

Both medications are approved for to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, to include clinically isolated syndrome. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.

Safety Considerations

DIMETHYL FUMARATE carries 4 FDA warnings. GLATIRAMER carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

DIMETHYL FUMARATE vs FINGOLIMOD→DIMETHYL FUMARATE vs TERIFLUNOMIDE→DIMETHYL FUMARATE vs SIPONIMOD→DIMETHYL FUMARATE vs PONESIMOD→CLADRIBINE vs DIMETHYL FUMARATE→FINGOLIMOD vs GLATIRAMER→

Loading comparison data...

DIMETHYL FUMARATE vs GLATIRAMER

Compare DIMETHYL FUMARATE (Dimethyl Fumarate) and GLATIRAMER (Glatiramer Acetate) — clinical data, side effects, and patient experiences.

DIMETHYL FUMARATE

Dimethyl Fumarate, Tecfidera · Other

How it works

12.1 Mechanism of Action The mechanism by which dimethyl fumarate (DMF) exerts its therapeutic effect in multiple sclerosis is unknown. DMF and the metabolite, monomethyl fumarate ...

Approved for

1 INDICATIONS AND USAGE Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)

to include clinically isolated syndrome

relapsing-remitting disease

and active secondary progressive disease

OralTablet

GLATIRAMER

Glatiramer Acetate · Other

How it works

12.1 Mechanism of Action The mechanism(s) by which glatiramer acetate exerts its effects in patients with MS are not fully understood. However, glatiramer acetate is thought to act...

Approved for

1 INDICATIONS AND USAGE Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS)

to include clinically isolated syndrome

relapsing-remitting disease

and active secondary progressive disease

SubcutaneousTablet

Quick Comparison

DIMETHYL FUMARATEGLATIRAMER

Drug Class

Other

Route

Oral

Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

DIMETHYL FUMARATE

Nausea

1-10%

Diarrhea

1-10%

Fatigue

1-10%

Vomiting

1-10%

Drug Not Working

1-10%

Headache

0.1-1%

Itching

0.1-1%

Falls

0.1-1%

GLATIRAMER

Injection Site Pain

>10%

Drug Not Working

1-10%

Injection Site Reaction

1-10%

Fatigue

1-10%

Shortness of Breath

1-10%

Falls

1-10%

Nausea

0.1-1%

Dizziness

0.1-1%

FDA Warnings

DIMETHYL FUMARATE

5 WARNINGS AND PRECAUTIONS Anaphylaxis and angioedema: Discontinue and do not restart dimethyl fumarate if these occur
2 ) Herpes zoster and other serious opportunistic infections: Consider withholding dimethyl fumarate in cases of serious infection until the infection has resolved
PML is an opportunistic viral infection of the brain caused by the JC virus (JCV) that typically only occurs in patients who are immunocompromised, and that usually leads to death or severe disability
A fatal case of PML occurred in a patient who received dimethyl fumarate for 4 years while enrolled in a clinical trial

GLATIRAMER

5 WARNINGS AND PRECAUTIONS • Immediate Post-Injection Reaction (flushing, chest pain, palpitations, tachycardia, anxiety, dyspnea, throat constriction, and/or urticaria), may occur within seconds to minutes after injection and are generally transient and self-limiting ( 5
6 ) • Glatiramer Acetate Products and Administration Errors: Using an optional autoinjector that is not compatible for use with Mylan’s glatiramer acetate injection may increase the risk for medication errors, such as dose omission or administration of a partial dose
1 Anaphylactic Reactions Life-threatening and fatal anaphylaxis has been reported with glatiramer acetate injection [see Adverse Reactions (6
Glatiramer acetate injection is contraindicated in patients with a history of hypersensitivity reactions to glatiramer acetate injection, including anaphylaxis [see Contraindications (4) ]

Clinical Trial Data

No head-to-head clinical studies found for DIMETHYL FUMARATE vs GLATIRAMER.

DIMETHYL FUMARATE vs GLATIRAMER: What You Should Know

Key Differences

Shared Indications

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.